Oruka Therapeutics, Inc. (ORKA) — Strategic Asset Allocation Index
Oruka Therapeutics, Inc. (ORKA) has a Strategic Asset Allocation Index of 31.2% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $151.76 Million) total $151.76 Million, measured against net assets of $486.79 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see market cap of Oruka Therapeutics, Inc..
SAAI
Strategic Assets
PP&E
Net Assets
Oruka Therapeutics, Inc. Strategic Asset Allocation Index (2024–2024)
This chart shows how Oruka Therapeutics, Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the index stands at 31.2%, representing strategic assets of $151.76 Million against net assets of $486.79 Million USD. See Oruka Therapeutics, Inc. (ORKA) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Oruka Therapeutics, Inc. (2024–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Oruka Therapeutics, Inc. from 2024 to 2024, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore ORKA net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 4.7% | $18.07 Million | $- | $18.07 Million | $382.22 Million | — |